ghk-cu research news for Sale | Tripeptide-1 | 3rd-Party Tested GHK-Cu - Kairos Research Labs
Description
Versatility: Can be used with a wide variety of drugs and is compatible with many medication types
Expected 12-week outcome without AOD-9604: approximately 5-6 kg total weight loss, roughly 3.5-4 kg from fat, 1-2 kg from lean tissue and water
Some practitioners inject directly into the scalp (mesotherapy)
Kida, N
Recommended usage rate up to 1%
The agency also indicated it would soon remove the seven flagged compounds from the Category 2 restricted list in the interim a provisional measure that patients should not interpret as formal approval
